These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2223405)

  • 21. Current issues in the management of breast cancer.
    Hill AD; McDermott EW; O'Higgins NJ
    Ir Med J; 1996; 89(2):46-8. PubMed ID: 8682624
    [No Abstract]   [Full Text] [Related]  

  • 22. [Third revision of the National Consensus on Diagnosis and Treatment of Breast Cancer (second of three parts)].
    Ginecol Obstet Mex; 2010 Feb; 78(2):138-50. PubMed ID: 20939218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer in the elderly.
    Crivellari D; Aapro M; Leonard R; von Minckwitz G; Brain E; Goldhirsch A; Veronesi A; Muss H
    J Clin Oncol; 2007 May; 25(14):1882-90. PubMed ID: 17488987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of screen-detected breast cancer: audit of the first 100 cases in the Southampton and Salisbury breast screening programme.
    Campbell I; Royle G; Coddington R; Herbert A; Rubin C; Taylor I; Guyer P
    Ann R Coll Surg Engl; 1993 Jan; 75(1):13-7. PubMed ID: 8422137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current trends and therapeutic strategies in breast carcinoma. Introduction].
    Bresadola F; Marcotti E; Anania G
    Ann Ital Chir; 1999; 70(3):317-9. PubMed ID: 10466233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the benefits of adjuvant systemic therapy for women with early breast cancer.
    Grogan M; Tabar L; Chua B; Chen HH; Boyages J
    Br J Surg; 2001 Nov; 88(11):1513-8. PubMed ID: 11683751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic-predictive factors and therapeutic choices in invasive carcinoma of the breast].
    Puglisi F; Di Loreto C; Beltrami CA
    Ann Ital Chir; 1999; 70(3):335-41. PubMed ID: 10466235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four studies support adjuvant treatment of women with node-negative breast cancer.
    Oncology (Williston Park); 1989 Apr; 3(4):125-8, 133-4, 136 passim. PubMed ID: 2641322
    [No Abstract]   [Full Text] [Related]  

  • 34. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
    Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.
    Vogel VG
    Menopause; 2008; 15(4 Suppl):782-9. PubMed ID: 18596599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer in young women. Does it have special diagnostic, therapeutic and prognostic factors?].
    Body G
    Rev Fr Gynecol Obstet; 1994 Nov; 89(11):570-2. PubMed ID: 7817087
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.
    Younes M; Laucirica R
    Clin Cancer Res; 1997 Apr; 3(4):601-4. PubMed ID: 9815726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.